A new study suggests that patients are willing to use antibiotics without contacting a doctor. Here’s how execs can curb this and avoid antibiotic resistance.
Patients are willing to use antibiotics without contacting a medical professional, according to a study published in Antimicrobial Agents and Chemotherapy.
Related: Antibiotic stewardship programs: 4 case studies
This behavior can lead to overuse and misuse of antibiotics, and could lead to antibiotic resistance.
From April to August last year, study coauthor Larissa Grigoryan, an instructor in the department of family and community medicine, Baylor College of Medicine, Houston, and colleagues surveyed 400 patients from a socioeconomically and ethnically diverse primary care population in the waiting rooms of three primary care clinics around Houston, asking about their use of antibiotics in the past year. Two were public family medicine clinics serving diverse, mostly uninsured or underinsured patients. The third clinic served primarily managed care and privately insured patients.
Among the surveyed respondents, 5% had used antibiotics without a prescription in the prior 12 months. Overall, 25.4% said they would take antibiotics without consulting a medical professional, and 14.2% reported storing antibiotics at home, most of which were saved from previous prescriptions.
These rates were similar across race/ethnicity groups, according to the authors. “Sources of antibiotics used without prescriptions or stored for future use were stores or pharmacies in the U.S., ‘leftover’ antibiotics from previous prescriptions, antibiotics obtained abroad, or from a relative or friend. Respiratory symptoms were common reasons for using non-prescription antibiotics,” the authors wrote.
Grigoryan
“Respondents from public primary care clinics were more likely to endorse intended use than were private clinic patients,” Grigoryan says. “One of the reasons that one in four persons surveyed would take antibiotic without a prescription may be that it is inconvenient, difficult, or expensive to see a provider in a clinic setting.”
Executives may wish to consider whether medical care in their system could be made more accessible, patient-friendly, and available on demand, according to Grigoryan. “Perhaps telemedicine and electronic communication could fill this gap in many cases. If these patients were able to access a medical provider in a timely and convenient manner, in many cases the provider might deliver the reassuring message that antibiotics are not needed for many common scenarios-such as for colds and sinusitis-thus saving the patient the inconvenience, risk and expense of taking unnecessary antibiotics.”
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
The deliberate disconnection of Change Healthcare to ring fence a cyberattack entered its seventh day today. Prescribers are finding ways to get pharmacy claims processed, and UnitedHealth Group says disruption to the dispensing of prescriptions has been minimal. But independent pharmacies want more information and protection from financial consequences from pharmacy benefit managers.
Read More